Global Insulin API Market Growth 2019-2024

Published On: July 2019 | Report ID: 180167 | Category: Pharmaceuticals and HealthcarePages: 163

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

Insulin API is a relatively concentrated industry in China, The main production are concentrated in Novo Nordisk, Eli Lilly, Sanofi several companies but their products are for their own use. Gan Lee Tonghua Dongbao in recent years to expand production capacity, and they are the main providers of insulin API

The overall domestic policy for the development of insulin API is supported. Local governments have a lot of policies to support the development of the industry. But in recent years environmental protection requirements for the fermentation industry are also getting higher and higher.

According to this study, over the next five years the Insulin API market will register a 4.2% CAGR in terms of revenue, the global market size will reach US$ 2120 million by 2024, from US$ 1660 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Insulin API business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Insulin API market by product type, application, key manufacturers and key regions and countries.

This study considers the Insulin API value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Regular Human Insulin

Insulin Analogue

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Fast-acting

Premix

Long-acting

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Novo Nordisk

Sanofi-Aventis

Eli Lilly

Tonghua Dongbao

United Laboratory

Biocon

Torrent Pharma

Amphastar

Ganlee

Julphar Diabetes

Wockhardt

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Insulin API consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Insulin API market by identifying its various subsegments.

Focuses on the key global Insulin API manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Insulin API with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Insulin API submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Insulin API Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Insulin API Consumption 2014-2024

2.1.2 Insulin API Consumption CAGR by Region

2.2 Insulin API Segment by Type

2.2.1 Regular Human Insulin

2.2.2 Insulin Analogue

2.3 Insulin API Consumption by Type

2.3.1 Global Insulin API Consumption Market Share by Type (2014-2019)

2.3.2 Global Insulin API Revenue and Market Share by Type (2014-2019)

2.3.3 Global Insulin API Sale Price by Type (2014-2019)

2.4 Insulin API Segment by Application

2.4.1 Fast-acting

2.4.2 Premix

2.4.3 Long-acting

2.5 Insulin API Consumption by Application

2.5.1 Global Insulin API Consumption Market Share by Application (2014-2019)

2.5.2 Global Insulin API Value and Market Share by Application (2014-2019)

2.5.3 Global Insulin API Sale Price by Application (2014-2019)

3 Global Insulin API by Players

3.1 Global Insulin API Sales Market Share by Players

3.1.1 Global Insulin API Sales by Players (2017-2019)

3.1.2 Global Insulin API Sales Market Share by Players (2017-2019)

3.2 Global Insulin API Revenue Market Share by Players

3.2.1 Global Insulin API Revenue by Players (2017-2019)

3.2.2 Global Insulin API Revenue Market Share by Players (2017-2019)

3.3 Global Insulin API Sale Price by Players

3.4 Global Insulin API Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Insulin API Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Insulin API Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Insulin API by Regions

4.1 Insulin API by Regions

4.1.1 Global Insulin API Consumption by Regions

4.1.2 Global Insulin API Value by Regions

4.2 Americas Insulin API Consumption Growth

4.3 APAC Insulin API Consumption Growth

4.4 Europe Insulin API Consumption Growth

4.5 Middle East & Africa Insulin API Consumption Growth

5 Americas

5.1 Americas Insulin API Consumption by Countries

5.1.1 Americas Insulin API Consumption by Countries (2014-2019)

5.1.2 Americas Insulin API Value by Countries (2014-2019)

5.2 Americas Insulin API Consumption by Type

5.3 Americas Insulin API Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Insulin API Consumption by Countries

6.1.1 APAC Insulin API Consumption by Countries (2014-2019)

6.1.2 APAC Insulin API Value by Countries (2014-2019)

6.2 APAC Insulin API Consumption by Type

6.3 APAC Insulin API Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Insulin API by Countries

7.1.1 Europe Insulin API Consumption by Countries (2014-2019)

7.1.2 Europe Insulin API Value by Countries (2014-2019)

7.2 Europe Insulin API Consumption by Type

7.3 Europe Insulin API Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Insulin API by Countries

8.1.1 Middle East & Africa Insulin API Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Insulin API Value by Countries (2014-2019)

8.2 Middle East & Africa Insulin API Consumption by Type

8.3 Middle East & Africa Insulin API Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Insulin API Distributors

10.3 Insulin API Customer

11 Global Insulin API Market Forecast

11.1 Global Insulin API Consumption Forecast (2019-2024)

11.2 Global Insulin API Forecast by Regions

11.2.1 Global Insulin API Forecast by Regions (2019-2024)

11.2.2 Global Insulin API Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Insulin API Forecast by Type

11.8 Global Insulin API Forecast by Application

12 Key Players Analysis

12.1 Novo Nordisk

12.1.1 Company Details

12.1.2 Insulin API Product Offered

12.1.3 Novo Nordisk Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Novo Nordisk News

12.2 Sanofi-Aventis

12.2.1 Company Details

12.2.2 Insulin API Product Offered

12.2.3 Sanofi-Aventis Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Sanofi-Aventis News

12.3 Eli Lilly

12.3.1 Company Details

12.3.2 Insulin API Product Offered

12.3.3 Eli Lilly Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Eli Lilly News

12.4 Tonghua Dongbao

12.4.1 Company Details

12.4.2 Insulin API Product Offered

12.4.3 Tonghua Dongbao Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Tonghua Dongbao News

12.5 United Laboratory

12.5.1 Company Details

12.5.2 Insulin API Product Offered

12.5.3 United Laboratory Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 United Laboratory News

12.6 Biocon

12.6.1 Company Details

12.6.2 Insulin API Product Offered

12.6.3 Biocon Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Biocon News

12.7 Torrent Pharma

12.7.1 Company Details

12.7.2 Insulin API Product Offered

12.7.3 Torrent Pharma Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 Torrent Pharma News

12.8 Amphastar

12.8.1 Company Details

12.8.2 Insulin API Product Offered

12.8.3 Amphastar Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 Amphastar News

12.9 Ganlee

12.9.1 Company Details

12.9.2 Insulin API Product Offered

12.9.3 Ganlee Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 Ganlee News

12.10 Julphar Diabetes

12.10.1 Company Details

12.10.2 Insulin API Product Offered

12.10.3 Julphar Diabetes Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)

12.10.4 Main Business Overview

12.10.5 Julphar Diabetes News

12.11 Wockhardt

13 Research Findings and Conclusion

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@mrinsights.biz

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.